Durvalumab (D) in Combination with Olaparib (O) for Advanced, Previously Treated Non-Small Cell Lung Cancer (NSCLC).Daniel Desmond,Rasa Vilimas,Cristina Mullenix,Chen Zhao,Eva Szabo,Meenakshi Shelat,Madison Ballman,Susan Sansone,Seth M. Steinberg,Jung-Min Lee,Arun RajanJournal of Clinical Oncology（2022）引用 1|浏览25AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
